Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta

Go back to Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
Abbott Laboratories (NYSE: ABT) Delayed: 105.23 -0.29 (0.27%)
Previous Close $105.52    52 Week High $46.38 
Open $105.69    52 Week Low $36.00 
Day High $106.86    P/E 70.15 
Day Low $104.78    EPS $1.50 
Volume 6,470,800       

Amgen Inc (NASDAQ: AMGN) Delayed: 391.27 -1.9 (0.48%)
Previous Close $393.17    52 Week High $176.85 
Open $393.07    52 Week Low $133.64 
Day High $395.55    P/E 58.93 
Day Low $389.28    EPS $6.64 
Volume 2,921,761       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 48.63 +0.09 (0.19%)
Previous Close $48.54    52 Week High $45.58 
Open $48.82    52 Week Low $37.82 
Day High $49.16    P/E N/A 
Day Low $48.60    EPS $0.00 
Volume 2,405,233       

Human Genome Sciences, Inc. (NASDAQ: HGSI) Delayed: 14.24 --0 (-0%)
Previous Close $14.24    52 Week High $16.58 
Open $55.80    52 Week Low $6.51 
Day High $14.24    P/E N/A 
Day Low $14.24    EPS $-1.79 
Volume 557,147       

Johnson & Johnson (NYSE: JNJ) Delayed: 267.08 -2.04 (0.76%)
Previous Close $269.12    52 Week High $126.07 
Open $268.51    52 Week Low $94.28 
Day High $270.10    P/E 55.53 
Day Low $266.73    EPS $4.81 
Volume 6,124,727       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 53.38 -0.69 (1.28%)
Previous Close $54.07    52 Week High $35.13 
Open $54.07    52 Week Low $28.10 
Day High $54.29    P/E N/A 
Day Low $53.37    EPS $0.00 
Volume 1,344,325